search

menu

  • Research Research
    • Where science meets inspired minds

    • Back
    • Research
    • Our Science
    • Research Groups
    • Facilities & Platforms
    • Clinical research
    • Find a researcher
    • Publications
    • Knowledge Transfer
  • Careers & study Careers & study
    • Become a leader in cancer research

    • Back
    • Careers & study
    • Vacancies
    • Faculty
    • Scientific staff
    • Scientific support staff
    • Postdoctoral fellows
    • PhD Students
    • Operational staff
    • Clinical fellows
    • Life in Amsterdam
    • Student internships
  • News & Events News & Events
    • Check out our stories and events

    • Back
    • News & Events
    • News
    • Media & Press
    • Calendar
  • About us About us
    • Maximum impact for cancer patients

    • Back
    • About us
    • Our vision
    • Organization
    • Collaborations
    • Responsible Research
    • Support us
    • Visit us
    • Contact us
  • Support us
Support us
  • Home
  • Publications
  • Research
  • Publications
  • Article

International phase IV field study to validate the European Organisation for Research and Treatment of Cancer questionnaire for assessing the health-related quality of life of cancer survivors: The EORTC QLQ-SURV100.

Louis Fox ,
Marieke van Leeuwen ,
Jennifer M Jones ,
Amal Al-Omari ,
Haneen Abaza ,
Muna Al-Khaifi ,
Martin Eichler ,
Sue Hartup ,
Galina Velikova ,
Nanna Friðriksdóttir ,
Juhee Cho ,
Nathalie Vanlaer ,
Anne Rogiers ,
Stefania Costi ,
Silvia Soncini ,
Trille Kristina Kjær ,
Volker Arndt ,
Daniela Doege ,
Ali Alkan ,
Hiroto Ishiki ,
Elke Rammant ,
Jannike Baumann ,
Marianne Sinn ,
Maria Antonietta Annunziata ,
Juan Ignacio Arraras ,
Mieke Van Hemelrijck ,
Andrea Pace ,
Naomi Clatworthy ,
Victoria King ,
Lærke Kjær Tolstrup ,
Akihiko Shimomura ,
Meropi Kontogianni ,
Samantha C Sodergren ,
Nikolina Vukšić ,
Morten Aagaard Petersen ,
Jacobien M Kieffer ,
Michael Jefford ,
Tara Chalk ,
Teresa Young ,
Nayanaben Borda ,
Ofir Morag ,
Amelie Harle ,
Duška Petranović ,
Elena Meggiolaro ,
Silvia De Padova ,
Femke Jansen ,
Nazim Serdar Turhal ,
Chiara Maria Navarra ,
Ingo Baumann ,
Cecilie Delphin Amdal ,
Vassilios Vassiliou ,
Monica Pinto ,
Saiko Kurosawa ,
Ingvild Vistad ,
Muna Al-Balushi ,
Ahmad Al-Ghoche ,
Linda Dirven ,
Andreia Capela ,
Zeinab Elsayed ,
Sara Montemuiño ,
Patricia Willisch ,
Neil Aaronson ,
Lonneke van de Poll-Franse ,

Abstract

METHODS

The QLQ-SURV100 was administered to 1480 participants across 46 centres in 21 countries (31% breast cancer, 23% colorectal, 22% prostate, 24% other cancers), who had completed primary treatment 1-10 years earlier and had no evidence of active disease. Structural validity of the 21 multi-item questionnaire scales was assessed via confirmatory factor analysis; test-retest reliability via intraclass correlation coefficients (ICCs); construct validity through known-group comparisons; and cross-cultural validity and sex invariance through differential item functioning (DIF). Item response theory (IRT) analyses evaluated item redundancy and performance.

CONCLUSIONS

The EORTC QLQ-SURV100 showed satisfactory structural validity, test-retest reliability and construct validity; limited item redundancy; and measurement invariance across the sex and language groups examined.

RESULTS

The QLQ-SURV100 showed strong structural validity (Comparative Fit Index = 0.951; Tucker-Lewis Index = 0.944; Root Mean Square Error of Approximation = 0.046), with most standardised factor loadings > 0.7. Test-retest ICCs exceeded 0.7 for 27 of 35 scales and 0.6 for 34 scales. Known-groups analyses supported most hypotheses, confirming sensitivity to treatment, comorbidity, age, sex, and education. DIF analysis indicated minor cross-cultural item bias, but no sex-related DIF. IRT analysis found no redundant items.

INTRODUCTION

Cancer survivors face unique and persistent health-related quality of life (HRQoL) challenges. Existing HRQoL questionnaires for survivors lack content regarding chronic physical issues and have typically included limited cancer types and languages/cultures, affecting breadth of content and generalisability. We developed and validated the EORTC QLQ-SURV100, a questionnaire to assess HRQoL in disease-free survivors of diverse cancers. A conceptual framework of HRQoL in cancer survivors, developed in previous study phases and conceptualised as survivors' self-reported physical, mental and social functioning and well-being, formed the basis for questionnaire content.

More about this publication

European journal of cancer (Oxford, England : 1990)

Volume 245
Pages 116959
Publication date 22-07-2026

Full text links

Publisher website (DOI) 10.1016/j.ejca.2026.116959
Europe PubMed Central 42541912
Pubmed 42541912

Where science meets inspired minds

Contact

Plesmanlaan 121
1066CX Amsterdam

020 512 9111 communicatie@nki.nl

Quick links

  • Vacancies
  • News
  • Contact us
  • Media & Press

Follow us on

Disclaimer
Privacy statement
Cookies
Change cookie settings

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.